LU103183B1 - Method for building prognosis model of lung adenocarcinoma based on cuproptosis-related genes - Google Patents
Method for building prognosis model of lung adenocarcinoma based on cuproptosis-related genes Download PDFInfo
- Publication number
- LU103183B1 LU103183B1 LU103183A LU103183A LU103183B1 LU 103183 B1 LU103183 B1 LU 103183B1 LU 103183 A LU103183 A LU 103183A LU 103183 A LU103183 A LU 103183A LU 103183 B1 LU103183 B1 LU 103183B1
- Authority
- LU
- Luxembourg
- Prior art keywords
- lung adenocarcinoma
- prognosis model
- genes
- survival
- prognosis
- Prior art date
Links
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 title claims abstract description 151
- 201000005249 lung adenocarcinoma Diseases 0.000 title claims abstract description 151
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 112
- 238000004393 prognosis Methods 0.000 title claims abstract description 81
- 238000000034 method Methods 0.000 title claims abstract description 51
- 230000004083 survival effect Effects 0.000 claims abstract description 87
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 45
- 229910052802 copper Inorganic materials 0.000 claims abstract description 45
- 239000010949 copper Substances 0.000 claims abstract description 45
- 230000037361 pathway Effects 0.000 claims abstract description 39
- 230000034994 death Effects 0.000 claims abstract description 37
- 230000000694 effects Effects 0.000 claims abstract description 35
- 230000014509 gene expression Effects 0.000 claims abstract description 22
- 238000012216 screening Methods 0.000 claims abstract description 16
- 101000634537 Homo sapiens Neuronal PAS domain-containing protein 2 Proteins 0.000 claims abstract description 9
- 101000666658 Homo sapiens Rho-related GTP-binding protein RhoV Proteins 0.000 claims abstract description 9
- 101000669432 Homo sapiens Transducin-like enhancer protein 1 Proteins 0.000 claims abstract description 9
- 102100029045 Neuronal PAS domain-containing protein 2 Human genes 0.000 claims abstract description 9
- 102100038400 Rho-related GTP-binding protein RhoV Human genes 0.000 claims abstract description 9
- 102100039362 Transducin-like enhancer protein 1 Human genes 0.000 claims abstract description 9
- 102100034277 Ankyrin repeat domain-containing protein 29 Human genes 0.000 claims abstract description 8
- 101000780130 Homo sapiens Ankyrin repeat domain-containing protein 29 Proteins 0.000 claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims description 84
- 238000004422 calculation algorithm Methods 0.000 claims description 16
- 238000012549 training Methods 0.000 claims description 13
- 230000002103 transcriptional effect Effects 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 9
- 210000002919 epithelial cell Anatomy 0.000 claims description 9
- 201000011510 cancer Diseases 0.000 claims description 8
- 238000010200 validation analysis Methods 0.000 claims description 6
- 238000007637 random forest analysis Methods 0.000 claims description 5
- 238000010276 construction Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims 1
- 238000010586 diagram Methods 0.000 description 14
- 238000011282 treatment Methods 0.000 description 13
- 230000030833 cell death Effects 0.000 description 10
- 238000011337 individualized treatment Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 4
- 101150027068 DEGS1 gene Proteins 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 229910001431 copper ion Inorganic materials 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010201 enrichment analysis Methods 0.000 description 2
- 230000004806 ferroptosis Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 238000010837 poor prognosis Methods 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 102100024396 Adrenodoxin, mitochondrial Human genes 0.000 description 1
- 101001120734 Ascaris suum Pyruvate dehydrogenase E1 component subunit alpha type I, mitochondrial Proteins 0.000 description 1
- 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 description 1
- 102100031611 Collagen alpha-1(III) chain Human genes 0.000 description 1
- 102100037085 Complement C1q subcomponent subunit B Human genes 0.000 description 1
- 102000009508 Cyclin-Dependent Kinase Inhibitor p16 Human genes 0.000 description 1
- 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 1
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100027152 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial Human genes 0.000 description 1
- 101000833098 Homo sapiens Adrenodoxin, mitochondrial Proteins 0.000 description 1
- 101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 description 1
- 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 description 1
- 101000740680 Homo sapiens Complement C1q subcomponent subunit B Proteins 0.000 description 1
- 101001122360 Homo sapiens Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial Proteins 0.000 description 1
- 101001005211 Homo sapiens Lipoyltransferase 1, mitochondrial Proteins 0.000 description 1
- 101000798109 Homo sapiens Melanotransferrin Proteins 0.000 description 1
- 101000967073 Homo sapiens Metal regulatory transcription factor 1 Proteins 0.000 description 1
- 101001030197 Homo sapiens Myelin transcription factor 1 Proteins 0.000 description 1
- 101000979599 Homo sapiens Protein NKG7 Proteins 0.000 description 1
- 101001120726 Homo sapiens Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial Proteins 0.000 description 1
- 101001137451 Homo sapiens Pyruvate dehydrogenase E1 component subunit beta, mitochondrial Proteins 0.000 description 1
- 101000584590 Homo sapiens Receptor activity-modifying protein 2 Proteins 0.000 description 1
- 101000946863 Homo sapiens T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 1
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
- 101000946833 Homo sapiens T-cell surface glycoprotein CD8 beta chain Proteins 0.000 description 1
- 238000010824 Kaplan-Meier survival analysis Methods 0.000 description 1
- 102100025853 Lipoyltransferase 1, mitochondrial Human genes 0.000 description 1
- 102100030612 Mast cell carboxypeptidase A Human genes 0.000 description 1
- 102100040514 Metal regulatory transcription factor 1 Human genes 0.000 description 1
- 108091006676 Monovalent cation:proton antiporter-3 Proteins 0.000 description 1
- 101710119292 Probable D-lactate dehydrogenase, mitochondrial Proteins 0.000 description 1
- 102100023370 Protein NKG7 Human genes 0.000 description 1
- 102100026067 Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial Human genes 0.000 description 1
- 102100035711 Pyruvate dehydrogenase E1 component subunit beta, mitochondrial Human genes 0.000 description 1
- 102100030696 Receptor activity-modifying protein 2 Human genes 0.000 description 1
- 102100035891 T-cell surface glycoprotein CD3 delta chain Human genes 0.000 description 1
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
- 102100034928 T-cell surface glycoprotein CD8 beta chain Human genes 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 101150045640 VWF gene Proteins 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000001650 focal adhesion Anatomy 0.000 description 1
- 230000017945 hippo signaling cascade Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Theoretical Computer Science (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Evolutionary Biology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Software Systems (AREA)
- Artificial Intelligence (AREA)
- Physiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310725068.5A CN116758986A (zh) | 2023-06-16 | 2023-06-16 | 一种基于铜死亡相关基因的肺腺癌预后模型的构建方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU103183B1 true LU103183B1 (en) | 2024-01-31 |
Family
ID=87947411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU103183A LU103183B1 (en) | 2023-06-16 | 2023-07-31 | Method for building prognosis model of lung adenocarcinoma based on cuproptosis-related genes |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN116758986A (zh) |
| LU (1) | LU103183B1 (zh) |
-
2023
- 2023-06-16 CN CN202310725068.5A patent/CN116758986A/zh active Pending
- 2023-07-31 LU LU103183A patent/LU103183B1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| CN116758986A (zh) | 2023-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112048559B (zh) | 基于m6A相关的IncRNA网络胃癌预后的模型构建及临床应用 | |
| CN111128299B (zh) | 一种结直肠癌预后显著相关ceRNA调控网络的构建方法 | |
| CN111435608B (zh) | 一种基于深度学习的蛋白质药物结合位点预测方法 | |
| CN106815486B (zh) | 一种个性化用药的系统药理学方法 | |
| CN111128385B (zh) | 一种用于食管鳞癌的预后预警系统及其应用 | |
| CN108335756B (zh) | 鼻咽癌数据库及基于所述数据库的综合诊疗决策方法 | |
| CN108206056B (zh) | 一种鼻咽癌人工智能辅助诊疗决策终端 | |
| CN111653314B (zh) | 一种分析识别淋巴管浸润的方法 | |
| CN111440869A (zh) | 一种用于预测原发性乳腺癌发生风险的dna甲基化标记物及其筛选方法和应用 | |
| CN112481378A (zh) | 基于乳腺癌单细胞转录组测序分析的乳腺癌患者复发风险20基因预测模型 | |
| CN115762792A (zh) | 一种基于lncRNA的优化模型预测膀胱癌患者生存预后的方法 | |
| CN114913919A (zh) | 一种单基因病遗传变异智能解读及报告的方法、系统及服务器 | |
| CN108320797B (zh) | 一种鼻咽癌数据库及基于所述数据库的综合诊疗决策方法 | |
| CN113584175A (zh) | 一组评估肾乳头状细胞癌进展风险的分子标记及其筛选方法和应用 | |
| CN113362895A (zh) | 一种预测抗癌药物反应相关基因的综合分析方法 | |
| LU103183B1 (en) | Method for building prognosis model of lung adenocarcinoma based on cuproptosis-related genes | |
| Liu et al. | Retyping of triple‐negative breast cancer based on clustering method | |
| CN112746108B (zh) | 用于肿瘤预后分层评估的基因标志物、评估方法及应用 | |
| Reddy et al. | Real-time data mining-based cancer disease classification using KEGG gene dataset | |
| CN117766024B (zh) | 一种卵巢癌cd8+ t细胞相关预后评估方法、系统及其应用 | |
| KR20210080766A (ko) | 암 환자의 유전자 네트워크 생성 및 예후 예측을 위한 유전자 쌍 발굴 방법과 시스템 | |
| Blazadonakis et al. | Complementary gene signature integration in multiplatform microarray experiments | |
| Schreidah et al. | Current status of artificial intelligence methods for skin cancer survival analysis: a scoping review | |
| CN114520060B (zh) | 一种基于网络推理的药物通路预测方法 | |
| Li et al. | Using the SVM Method for Lung Adenocarcinoma Prognosis Based on Expression Level |